Not available
Quote | Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)
Last: | $966.30 |
---|---|
Change Percent: | -0.78% |
Open: | $971.04 |
Close: | $966.30 |
High: | $976.75 |
Low: | $962.41 |
Volume: | 309,698 |
Last Trade Date Time: | 03/27/2024 03:00:00 am |
News | Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)
2024-03-28 08:00:00 ET Are stock splits back in style? About two years ago, a number of high-profile corporations made such moves after their shares rose to unwieldy levels. Now, Chipotle , one of the leading fast-casual restaurant chains, is on the verge of conducting a 50-for-1 stock ...
2024-03-26 14:36:26 ET Summary Regeneron Pharmaceuticals, Inc.'s Eylea HD reinforces its market dominance in treating wet AMD, competing effectively against biosimilars and Roche's Vabysmo. Libtayo's revenue growth is impressive, with expectations to become a blockbuster, enhancin...
Message Board Posts | Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $REGN News Article - Wall Street Has High Hopes for These 2 Nasdaq Stocks | whytestocks | investorshangout | 03/24/2023 4:45:46 PM |
whytestocks: $REGN News Article - Why Shares of Regeneron Are Rising Thursday | whytestocks | investorshangout | 03/23/2023 4:15:52 PM |
whytestocks: $REGN News Article - Dupixent (dupilumab) Demonstrates Potential to Become First Biolog | whytestocks | investorshangout | 03/23/2023 2:05:57 PM |
$REGN clearly states in their filing that the | zj3001 | investorshub | 03/21/2023 1:55:21 PM |
anyone on this board know anything about regn | 1jas | investorshub | 03/19/2023 7:00:28 PM |
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
2024-03-28 08:00:00 ET Are stock splits back in style? About two years ago, a number of high-profile corporations made such moves after their shares rose to unwieldy levels. Now, Chipotle , one of the leading fast-casual restaurant chains, is on the verge of conducting a 50-for-1 stock ...
2024-03-26 13:15:05 ET RBC Capital analyst issues BUY recommendation for REGN on March 26, 2024 10:01AM ET. The previous analyst recommendation was Buy. REGN was trading at $958.6051 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current...
2024-03-26 13:15:05 ET Morgan Stanley analyst issues UNDERPERFORM recommendation for REGN on March 26, 2024 10:01AM ET. The previous analyst recommendation was Underperform. REGN was trading at $958.6051 at issue of the analyst recommendation. The overall analyst consens...